Fidelity SPDR Advertisement
Home > Boards > US Listed > Biotechs > Amarin Corp. PLC ADS (AMRN)

Leerink's biotech analyst holds an analyst/industry conference call

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
krunchtimepicks Member Profile
 
Followed By 9
Posts 1,475
Boards Moderated 0
Alias Born 03/05/06
160x600 placeholder
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 8/25/2014 6:00:43 AM
(DEL AM) "Edgar (US Regulatory)" - 8/15/2014 4:19:36 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/7/2014 4:21:04 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/7/2014 4:18:55 PM
Securities Registration Statement (simplified Form) (s-3) "Edgar (US Regulatory)" - 8/7/2014 4:16:15 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/10/2014 4:31:53 PM
Confidential Treatment Order (ct Order) "Edgar (US Regulatory)" - 6/26/2014 4:25:27 PM
Rick Harrison of Television's "Pawn Stars®" Discusses His Revelations on Seeking Treatment for His Very High Triglycerides i... "PR Newswire (US)" - 6/25/2014 6:30:00 AM
Amarin Announces Publication of Case Study Results Describing Reductions in Multiple Lipid Parameters for Individual Hyperlip... "Marketwired" - 6/11/2014 7:00:00 AM
Amarin to Present at the Goldman Sachs 2014 Global Healthcare Conference "Marketwired" - 6/4/2014 8:00:00 AM
Amarin to Present at the Jefferies 2014 Global Healthcare Conference "Marketwired" - 5/29/2014 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/21/2014 5:02:20 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/15/2014 6:15:26 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/9/2014 7:09:19 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/9/2014 7:07:19 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/31/2014 4:41:32 PM
Biotech Equities Technical Study -- Research on Prana Biotechnology, Amarin, United Therapeutic, and OPKO Health "PR Newswire (US)" - 3/28/2014 12:19:00 PM
Amarin Corporation plc. Analyst Report: Special Situation \ Turnaround Opportunity in Biopharmaceuticals - Targeting large e... "PR Newswire (US)" - 3/28/2014 7:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/14/2014 4:46:13 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/13/2014 4:32:07 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/13/2014 4:31:29 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/13/2014 4:31:29 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/13/2014 4:31:29 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/13/2014 4:31:14 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/13/2014 4:31:14 PM
krunchtimepicks   Wednesday, 03/09/11 04:25:47 PM
Re: None
Post # of 33298 
Leerink's biotech analyst holds an analyst/industry conference call
Biotech Analyst Schwartz discusses prospects for Amarin's AMR-101 in the treatment of mixed Dyslipidemia: previewing the ANCHOR Study on an Analyst/Industry conference call being held on March 10 at 11 am hosted by Leerink.

www.theflyonthewall.com/.../AMRNid1391681/AMRN-Leerinks-biotech-analyst-holds-an-analystindustry-conference-call

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist